CAPS Medical announces Harel Gadot to its Board as Executive Chairman along with $3.5m Series A funding led by Chasing Value Asset Management and Israel Investment Fund Group
– ISRAEL, Netanya – CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma device for cancer treatment, today announced the completion of a $3.5 million Series A financing round led by Chasing Value Asset Management and the Los Angeles-based Israel Investment Fund Group alongside other investors including the Technion Research and Development Foundation and XACT Robotics, a portfolio company of MEDX Ventures Group,
XACT Robotics will add strategic capabilities to enhance the company’s solid tumor treatment portfolio capabilities.…
